FHD-286 in Subjects With Metastatic Uveal Melanoma
Condition:   Metastatic Uveal Melanoma Intervention:   Drug: FHD-286 Sponsors:   Foghorn Therapeutics Inc.;   Syneos Health Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 10, 2021 Category: Research Source Type: clinical trials